[Skip to Content]

Upstate Active Clinical Trials

Study Title:

ANHL1931 A Randomized Phase 3 Trial of Nivolumab (NSC# 748726, IND# 125462) in Combination with Chemo-immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-cell Lymphoma

What is the purpose of the study? (in Layman's terms, please describe the study)

treatment

Upstate Institutional Review Board (IRB) Number:

1774513

Study/Protocol ID:

ANHL1931

Study Phase:

3

Patient Age Group:

Adults and Children

Principal Investigator:

Melanie A Comito

What is involved if I participate?

  • How long is the study?
    N/A
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    N/A

Where will the study take place?

Upstate Pediatric Cancer Center

Other Information:

N/A

ClinicalTrials.Gov ID:

NCT04759586

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Karen B Bilynsky
Phone: 315-464-7601
Email: [email protected]

Return to Previous Page || Search Again

Top